Clinical trials
Terminated Phase 3 Myelodysplastic Syndromes trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| European Society for Blood and Marrow Transplantation | 1 |
| Fondazione Italiana Sindromi Mielodisplastiche-ETS | 1 |
| Gilead Sciences | 1 |
| Goethe University | 1 |
| Hackensack Meridian Health | 1 |
| Hospital Israelita Albert Einstein | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
| Kiadis Pharma | 1 |
| Kyntra Bio | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 20 |
| Leukemia, Myeloid, Acute | 7 |
| Leukemia, Myelomonocytic, Chronic | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 |
| Myeloproliferative Disorders | 3 |
| Anemia | 2 |
| Anemia, Refractory, with Excess of Blasts | 2 |
| Graft vs Host Disease | 2 |
| Infections | 2 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.